IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Teva Pharmaceutical FIN

CUSIP: 88165FAF9 | 1 institutional holders

Quarters

Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2021

Highlander Capital Management, LLC28,000
0.0% of portfolio›$28
StyleTurnoverLocationFiled
Highlander Capital Management, LLC
28,000$280.0%N/AN/AShort Hills, NJ2021-11-15